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a b s t r a c t
Aim of the study: Emilia sonchifolia (L.) DC. (Asteraceae) is a medicinal plant traditionally used in Brazilian
folkmedicine to treat asthma, fever, cuts,wounds and rheumatism. This studywas conducted to establish
the antinociceptive properties of hydroethanolic extract from aerial parts of Emilia sonchifolia in mice
using chemical and thermal models of nociception.
Materials and methods: To evaluate the antinociceptive effect of Emilia sonchifolia hydroethanolic extract
(EsHE) administered by oral route, peripheral (acetic acid-induced abdominal writhing and formalin),
spinal (tail ﬂick) and supra-spinal (hot plate) behavioral models of acute pain were used. High-
performance liquid chromatography (HPLC) was used to determine the ﬁngerprint chromatogram of
the EsHE.
Results: The EsHE at test doses of 100 and 300mg/kg, p.o. clearly demonstrated antinociceptive activ-pioids
ain
ity in all tests. The extract had a stronger antinociceptive effect than morphine. Administration of the
opioid receptor antagonist, naloxone, completely inhibited the antinociceptive effect induced by EsHE
(100mg/kg). The presence of phenolic compounds in the extract of Emilia sonchifoliawas conﬁrmedusing
HPLC.
Conclusion: The extract of Emilia sonchifolia markedly exhibits opioid-mediated anti-nociceptive activity
action in mice. Thus, may be useful in the treatment of inﬂammatory hyperalgesic disorders, which
of its
 supports previous claims
. Introduction
Emilia sonchifolia is a traditionally used medicinal plant found
n most tropical and subtropical regions worldwide. Various parts
f the plant are used for the treatment of diseases (Lara et al.,
003; Matos et al., 1991; Singh et al., 2008). This weed is used in
thnomedicine against inﬂammation, eye sores, convulsion, cuts,
ounds, rheumatismand insect bites (Agra et al., 2007;Matos et al.,
991; Muko and Ohiri, 1999; Perry, 1982; Shylesh and Padikkala,
999; Shylesh et al., 2005). In Brazilian traditional medicine, aerial
arts of Emilia sonchifolia, popularly known as “serralhinha” or
falsa-serralha” (Agra et al., 2007; Neto and de Morais, 2003).
The methanolic extract of Emilia sonchifolia has been reported
o have anti-tumor property (Shhylesh and Padikkala, 2000;
hylesh et al., 2005), anti-inﬂammatory (Muko and Ohiri, 1999)
nd antioxidant activity (Gayathri Devi et al., 2006; Kawaree and
howwanapoonpoh, 2009; Shylesh and Padikkala, 1999). In addi-
ion, anticonvulsant activity of aqueous extract has previously
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been reported (Asije et al., 2006). Phytochemical studies indicated
that the aerials parts of Emilia sonchifolia contain alkaloids, and
ﬂavonoids and terpernes (Fu et al., 2002; Lija et al., 2006; Srinivasan
and Subramanian, 1980). In addition, kaempherol-3-d-galactoside,
quercitrin, quercetin, rutin, ursolic acid, senkirkine, doronine, -
sitosterol and stigmasterol are previous isolated from the Emilia
sonchifolia (Srinivasan and Subramanian, 1980; Cheng and Röder,
1986; Gao et al., 1993).
Many medicinal plants provide relief of symptoms comparable
to that of conventional medicinal agents. Therefore, the present
study was aimed at evaluating the scientiﬁc basis for the tradi-
tional use of Emilia sonchifolia using chemical and thermal models
of nociception.
2. Materials and methods
2.1. Plant material
Open access under the Elsevier OA license.Emilia sonchifolia (L.) DC. (Asteraceae) was collected in Alfenas,
Minas Gerais, Brazil. Dr. G. Alves-da-Silva, Department of Phar-
macy of Federal University of Alfenas, identiﬁed the plant, and the
voucher specimen is deposited at the Herbarium of Federal Univer-
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.2. Preparation of the plant extracts and reference drugs
The aerial parts of Emilia sonchifolia were dried in an oven at
0 ◦C and powdered. The Emilia sonchifolia hydroethanolic extract
EsHE)was obtainedbymaceration in 50%hydro-alcoholic solution
or 48h, at room temperature, and this procedure was repeated
wice. The EsHE was concentrated on a rotary evaporator and then
ried with a spray dryer (Büchi Mini Spray Dryer B-290). The yield
f theEsHEwas6.0%. The residueswereused fordeterminingbioac-
ivity.
.3. Analysis of EsHE by high performance liquid chromatography
High performance liquid chromatography (HPLC) analysis of
he EsHE was performed in Shimadzu LC-100 HPLC using a Shi-
adzu CLC-ODS (250-4, 6mm) C18 column with a 5m particle
ize.Mobile phaseswere composedof a (A) 0.5mM/l aqueous acetic
cid and (B) 0.5% acetic acid inmethanol. The gradient of themobile
hases (A:B) used for separation were 0–30min (10:90 to 0:100)
nd 45min (0:100) with a solvent ﬂow rate of 1.0ml/min, an injec-
ion volume of 20l at a concentration of 1mg/ml. The eluent was
etected with a photodiode array detector (DAD) with UV light at
72nm. LC solution software (Shimadzu) was used for data collec-
ion.
.4. Assessment of antinociceptive activity of EsHE
Adultmale Swissmice (22–30g), obtained from the Central Ani-
al Facility of the Federal University of Alfenas,were housed under
ontrolled light (12:12h light–dark cycle; lights on at 06:00 am)
nd temperature conditions (23±1 ◦C), with access to water and
ood ad libitum. The animalswere allowed to habituate to the hous-
ng facilities for at least 1 week before the experiments began. All
xperiments were conducted in accordance with the Declaration
f Helsinki on the welfare of experimental animals and with the
pproval of the Ethics Committee of the Federal University of Alfe-
as.
Animals were treated with the EsHE (30, 100 and 300mg/kg)
r with vehicle (1% sodium carboxymethylcellulose suspension
n distilled water) given by the p.o. 1h before the experiments.
o assess the possible participation of the opioidergic system in
he Emilia sonchifolia antinociception, mice were pre-treated with
on-selective opioid receptor antagonist, naloxone (0.4mg/kg),
hich was injected 15min before the administration of the EsHE
100mg/kg; p.o.) and morphine, and tested using the writhing, for-
alin, tail-ﬂick and hot plate tests. Indomethacin (10mg/kg) and
orphine sulphate (1 or 10mg/kg) in vehicle were used as refer-
nce drugs (Vilela et al., 2009). Test drugswere orally administered,
xcept for morphine sulphate and naloxone, which was intraperi-
oneally administered in an equivalent volume of 10ml/kg body
eight of the animal.
.4.1. Acetic acid-induced writhing in mice
Acetic acid (0.6%, v/v, 10ml/kg) was injected into the peritoneal
avities of mice, placed in a large glass cylinder, and the inten-
ity of nociceptive behavior was quantiﬁed by counting the total
umber of writhes occurring between 0 and 20min after stimulus
njection, as described earlier (Collier et al., 1968). Oral treatments
p.o.) with vehicle, indomethacin or EsHE were given 1h prior to
cetic acid injection (n=6 per group). Morphine sulphate (1mg/kg)
as intraperitoneally administered (i.p.) 30minbefore the test. The
rithing response consists of a contraction of the abdominal mus-
le togetherwith a stretching of the hind limbs. The antinociceptive
ctivity was expressed as writhing scores over a period of 20min.rmacology 134 (2011) 348–353 349
2.4.2. Formalin test
A formalin solution (2.5% in 0.9% saline; 20l/paw)was injected
into the hind paw plantar surface (i.pl.), and the animals were indi-
vidually placed in transparent observation chambers, as previously
described (Santos and Calixto, 1997). Oral treatments (p.o.) with
vehicle, indomethacin, or EsHE were given 1h prior to formalin
injection (n=8 per group). Morphine sulphate was administrated
(10mg/kg; i.p.) 30min before the test. The time spent in licking
the injected paw was recorded and expressed as the total licking
time in the early phase (phase 1; 0–5min) and late phase (phase 2;
20–30min) after formalin injection.
2.4.3. Tail ﬂick test
The lower two-thirds of the tail were immersed in a beaker con-
taining water kept at 50±0.5 ◦C (Wang et al., 2000). The time in
seconds until the tail was withdrawn from the water was deﬁned
as the reaction time. The reaction time was then measured 0, 30,
60, and 120min after the oral administration of vehicle, EsHE and
morphine (10mg/kg), whereupon the reaction time of 0min is the
start of the test. The mice (n=8 per group) were exposed to hot
water for no longer than 20 s to avoid tissue injury.
2.4.4. Hot plate test
The hot plate was an electrically heated surface kept at a con-
stant temperature of 50.0±0.5 ◦C. Mice (n=8 per group) were
placed on the heated surface within the Plexiglas walls to con-
strain their locomotion on the plate, and the latency to a discomfort
reaction (licking of the paws or jumping) was recorded 0, 30, 60,
and 120min after oral administration of vehicle, EsHE or morphine
(10mg/kg), whereupon the reaction time of 0min is the start of the
test. A cut-off time of 20 s was chosen to indicate complete anal-
gesia and to avoid tissue injury. The latencies for paw licking or
jumping were recorded for each animal (Yamamoto et al., 2002).
2.5. Evaluation of acute toxicity of the Emilia sonchifolia extract
EsHE was orally administered to a group of mice, both male
and female. Thebehaviorparameters observedafter administration
were convulsion, hyperactivity, sedation, grooming, and increased
or decreased respiration during a period of 7 days. Food and water
were provided ad libitum.
2.6. Open-ﬁeld test
In order to discard the possible nonspeciﬁc muscle relaxants or
the sedative effects of extract, the motor performance of the mice
was evaluated on the open-ﬁeld apparatus (Archer, 1973; Vilela
et al., 2009). Groups of mice (n=8) received vehicle and EsHE (30,
100 and 300mg/kg) 1h before the test. Each animal was placed in
the center of the open arena and allowed to have free ambulation
for 5min observation of the locomotion frequency.
2.7. Statistical analysis
The data obtained were analyzed using the GraphPad software
program Version 4.0 and expressed as mean± S.E.M. Statistically
signiﬁcant differences between groups were calculated by the
application of an analysis of variance (ANOVA) followed by the
Newman–Keuls test. p-Values less than 0.05 (p<0.05) were used
as the signiﬁcance level.









































































The EsHE administrated at doses of 100 and 300mg/kg caused a
signiﬁcant increase in the response latency time as compared to the
control animals. In the hot plate test, oral treatment with EsHE at
doses of 100 and300mg/kg increased the latency timeas compared
Fig. 2. Effects ofEmilia sonchifoliahydroethanolic extract (EsHE) administeredorally
acetic acid-induced writhing movements in mice. Animals were treated orally
with vehicle, EsHE (doses 30, 100, and 300mg/kg), indomethacin (Indo; 10mg/kg),
morphine (Morp; 1mg/kg), naloxone+morphine (NLX+Morp; 0.4mg and 1mg,0.0 5.0 10.0 15.0 20.0 25
Fig. 1. High performance liquid chromatography proﬁles
. Results
.1. HPLC analysis
Fig. 1 shows theHPLCanalytical plot forEmilia sonchifoliaextract
t 272nm, the peak at 21.91min was identiﬁed as quercetin. The
eaks at 14.23, 18.28, 19.37, 19.77, 20.63 and 47.83min are com-
ounds that have characteristics in the UV bands for ﬂavonoids
Mabry et al., 1970). These ﬂavonoids and others compounds have
ot been identiﬁed and are under investigation.
.2. Acetic acid-induced writhing in mice
The oral administration of EsHE (at dose 100 and 300mg/kg)
aused a signiﬁcant reduction in the number of writhing episodes
nduced by acetic acid compared to the control. The inhibition of
rithes in percentage ranged from 63.0% and 80.2% after admin-
stration of indomethacin and morphine, respectively. Naloxone
opioid antagonist) given before the morphine or EsHE (100mg/kg,
.o.) abolished the antinociceptive responses in this test
Fig. 2).
.3. Formalin test
The EsHE at doses of 100 and 300mg/kg, p.o. had a signiﬁ-
ant antinociceptive activity compared to the control in both the
arly and late phases (p<0.05). The reference drug, indomethacin,
uppressed only the second phase of the formalin test (p<0.05).
n order to compare the antinociceptive activity of EsHE, a group
f mice was injected with morphine. This opioid signiﬁcantly
nhibited the total licking of both phases after formalin injection
p<0.05). Pre-treatment of mice with naloxone completely pre-
ented themorphineandEsHE (100mg/kg)antinociceptiveactivity
Fig. 3).30.0 35.0 40.0 45.0 50.0 min
ilia sonchifolia hydroethanolic extract traced at 272nm.
3.4. Tail ﬂick and hot plate tests induced nociception in micerespectively) ornaloxone+EsHE (NLX+EsHE;0.4mgand100mg, respectively)prior
to the acetic acid (0.6%, i.p.). Each column represents the mean with S.E.M. for six
mice in each group. The symbols denote the signiﬁcance levels (one-way ANOVA
followed by Newman–Keuls test): ***p<0.001 when compared with the control
group (vehicle); ##p<0.01 when compared with the morphine group; ††p<0.01
when compared with the EsHE (100mg/kg) group.
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Fig. 3. Effects of Emilia sonchifolia hydroethanolic extract (EsHE) given by oral
route on the nociceptive licking response induced by formalin in mice. Animals
were treated orally with vehicle, indomethacin (Indo; 10mg/kg), morphine (Morp;
10mg/kg), EsHE (doses 30, 100, and 300mg/kg), naloxone+morphine (NLX+Morp;
0.4mg and 10mg, respectively) or naloxone+EsHE (NLX+EsHE; 0.4mg and 100mg,
respectively), prior to formalin. The total time spent licking the hindpaw was
measured in the ﬁrst (upon) and second (button) phases after intraplantar injec-

















Fig. 4. Effects ofEmilia sonchifoliahydroethanolic extract (EsHE) administeredorally
in thehotplate test (panelA) and in the tail immersion test inmice (panel B). Animals
were pretreated orally with vehicle, morphine (Morp; 10mg/kg), EsHE (doses 30,
100, and 300mg/kg), naloxone+morphine (NLX+Morp; 0.4mg and 10mg, respec-
tively) or naloxone+EsHE (NLX+EsHE; 0.4mg and 100mg, respectively) prior to
the tests at 50 ◦C. Each column represents the mean with S.E.M. for eight mice inn each group. The symbols denote the signiﬁcance levels (one-way ANOVA fol-
owedbyNewman–Keuls test): *p<0.05; **p<0.01when comparedwith the control
roup (Vehicle); #p<0.05; ###p<0.001 when compared with the morphine group;
p<0.05; †††p<0.001 when compared with the EsHE (100mg/kg) group.
o the control group. As expected, administration of the vehicle
id not induce any antinociceptive effect. Morphine signiﬁcantly
ncreased the latency time in both tests (Fig. 4).
Trying to elucidate the mechanism by which EsHE induces
ntinociception, animals were pre-treated with naloxone. Fig. 3
hows that naloxone completely prevented themorphine antinoci-
eptive effect in tail ﬂick and hot plate models. Naloxone also
revented the antinociceptive activity of the EsHE at 100mg/kg
ose. Effect of naloxone against EsHE was comparable with those
btained with naloxone against morphine on both spinal and
upra-spinal models of analgesia..5. Open-ﬁeld test
A major concern in experiments designed to evaluate the anal-
esic action of new agents is whether pharmacological treatmenteach group. The symbols denote the signiﬁcance levels (one-way ANOVA followed
byNewman–Keuls test): *p<0.05when comparedwith the control group (Vehicle);
#p<0.05 when compared with the morphine group; †p<0.05 when compared with
the EsHE (100mg/kg) group.
causes other behavioral alterations, such as altering motor coor-
dination or sedation, which could be misinterpreted as analgesia.
Treatment with EsHE at 30–300mg/kg did not cause a reduction in
the numbers of crossings and rearings in the open-ﬁeld test when
compared to the control group (data not shown).
3.6. Acute toxicity
The EsHE at a dose of 0.5–5g/kg, p.o. given to mice had no effect
on their behavioral responses during the observation period of 7
daysafter administration.Nomortalitywasobservedup to7daysof
monitoring. The LD50 value of these extracts in mice was therefore
estimated to more than 5g/kg, p.o. As the effective dose used in
the present study (100mg/kg, p.o.) was 50-fold less than the dose
used in the acute toxicity test, it was safe to assume that the normal
doses of 100, and 300mg/kg, p.o. given to mice in this study were
safe.
4. DiscussionThe present study showed the antinociceptive effect of
the Emilia sonchifolia extract in different nociceptive responses
generated by a chemical or thermal noxious stimulus. The antinoci-
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voked no modiﬁcation in the overall behavior of the animals.
n this study, naloxone prevented the antinociception induced by
sHE, corroborating with the hypothesis that -opioid receptors
ust be involved.
The acetic acid-induced writhing is a sensitive test for assess-
ent of analgesic drug. However, it can be seen as a general
on-selective model for antinociceptive studies, since acetic acid
ndirectly induces the release of endogenous mediators, stimu-
ating the peripheral nociceptor and sensitive neurons that were
ensitive to the inﬂammatory mediators (Couture et al., 2001;
eraedt et al., 1980; Koster et al., 1959; Ribeiro et al., 2000).
he results showed that EsHE signiﬁcantly inhibited acetic acid-
nduced writhing responses. Therefore, one possible mechanism
f antinociceptive activity of EsHE could be due to the blockade
f the effect or the release of endogenous substances (arachidonic
cid metabolites) that sensitize and activate peripheral nocicep-
ors. The result of this test, however, does not ascertain whether
he anti-nociceptive effect was mediated by central or peripheral
rocess.
The neurogenic and inﬂammatory pain was evaluated using
ormalin test (Tjølsen et al., 1992). Subcutaneous injection of for-
alin into the animal hind paw evokes an array of stereotyped
ehaviors (Dubuisson and Dennis, 1977). The nociceptive response
o formalin occurs in a biphasic pattern; there is an initial acute
eriod (phase 1) and, after a short period of remission, phase 2
egins and consists of a longer period of sustained activity. The
hase 1 corresponds to acute nociceptive neurogenic pain, and is
ensitive to analgesic drugs that interact with opioid system. The
hase 2 corresponds to an inﬂammatory pain, dependent of several
nﬂammatory mediators release and action, and the expression of
ociceptive behavior in this phase is very sensitive to non-steroid
nti-inﬂammatory drugs as the cyclooxygenase inhibitors. Drugs
hat act primarily as central analgesics inhibit both phases while
eripherally acting drugs inhibit only the second phase (Abram
nd Olson, 1994; Manning, 1998; Rosland et al., 1990; Yamamoto
t al., 2002; Yamamoto and Nozaki-Taguchi, 2002). Once both ﬁrst
nd second phase behavioral hypernociception were affected by
he EsHE previous treatment, it can be suggested that not only
nti-inﬂammatory action (Muko and Ohiri, 1999) but also direct
nalgesic function can be present here. Therefore, the antinoci-
eptive activity of EsHE in formalin test is strongly attributed to
eripherally acting as well as centrally acting pain mediators. This
ould not be the ﬁrst time that an anti-inﬂammatory agent had
arallel and independent direct analgesic effect. In fact, the anal-
esic effect of both dipyrone and diclofenac involves not only
heir anti-inﬂammatory potential, but a peripheral antinocicep-
ive effect is associated with ATP-sensitive K+ channel (Alves and
uarte, 2002; Alves et al., 2004). The involvement of this channel
ay explain both spinal and peripheral analgesia, and the anti-
onvulsive use of the plant. To conﬁrm the participation of central
nalgesic system in the antinociceptive activity of EsHE, hot plate
est and tail-ﬂick test were employed.
In the tail immersion test, which consists of a thermal stim-
lus, an increase in the reaction time is generally considered to
e an important parameter for evaluating central antinociceptive
ctivity (Rujjanawate et al., 2003). Hot plate test is predominantly
spinal reﬂex or behavioral reaction and used to test supra-spinal
nalgesia in compounds. The plate heated to a constant tempera-
ure produces two behavioral components that can be measured
n terms of their reaction times, paw licking and jumping. Both are
onsidered to be supraspinally integrated responses. It is therefore,
elective for centrally acting analgesic drugs, like morphine, while
eripheral anti-inﬂammatory antinociceptive agents are found to
e inactive on thermal stimulus. These tests also revealed that the
ntinociceptiveeffect ofEmilia sonchifoliaextract onmice remained
resent for at least up to120minafter administrationof the extract.rmacology 134 (2011) 348–353
The Emilia sonchifolia extract was found to have antinociceptive
activity in the hot plate test, which is a speciﬁc central antinocicep-
tive test. The antinociceptive effects of EsHE involve supraspinal as
well as spinal components, as demonstrated by the use of the hot
plate (Yaksh and Rudy, 1976; Yaksh and Rudy, 1977; Yeung et al.,
1977) and tail immersion (Luttinger, 1985;Woolf et al., 1980) tests,
respectively.
One of the main strategies in nociception studies has been the
search for opioid analgesics acting at opioid receptors outside the
central nervous system (CNS), with the prospect of avoiding cen-
trally mediated side effects as tolerance and dependence (Benyhe,
1994; Vanegas and Tortorici, 2002). For the assessment of opioid
system involvement in the analgesic activity the mice were pre-
treatedwith an opioid antagonist, naloxone. In this study, naloxone
prevented the antinociceptive effect on both phases of the formalin
test, as well in writhing, tail-ﬂick and hot plate tests. Those results
suggest that, at least part of the anti-hyperalgesic effect observed
for the fractions is due to involvement of this system (-opioid)
since naloxone reverted the antinociceptive activity.
In conclusions, the results presented in this study suggest that
the hydroethanolic extract that was obtained from Emilia sonchi-
folia exhibited opioid-mediated antinociceptive activity in animal
models. The precise mechanisms that are involved in the produc-
tion of the antinociceptive response of Emilia sonchifolia extract are
not completelyunderstood, but theymaybecausedby thepresence
of ﬂavonoids and others aromatic compounds. Thus, may be use-
ful in the treatment of inﬂammatory hyperalgesic disorders, which
supports previous claims of its traditional use.
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